Atlas Trials

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

Clinical trial NCT03462615 · UNKNOWN

Trial details

NCT number
NCT03462615
Sponsor
Foundation for Innovative New Diagnostics, Switzerland
Status
UNKNOWN
Study type
OBSERVATIONAL
Plasmodium Falciparum MalariaPregnancy MalariaDiagnoses Disease
Start date
2018-04-01
Primary completion
2018-10-01
Enrollment
930

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.